Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye by merzdev | May 29, 2024 | News
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting by merzdev | Apr 2, 2024 | News
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board by merzdev | Mar 14, 2024 | News
Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership by merzdev | Mar 4, 2024 | NewsRead...
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., appoints ophthalmology innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair by merzdev | Feb 26, 2024 | NewsRead...
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. by merzdev | Jan 17, 2024 | NewsRead...
